https://www.selleckchem.com/pr....oducts/AZD1152-HQPA.
enotype-phenotype correlation, will further improve detection rates for patients with suspected CMT/HN disorders. Severe maternal morbidity (SMM) occurs in 1-2% of pregnancies. Despite the knowledge that a SMM event can contribute to poor fetal/neonatal outcomes, little is known about the preventability of these adverse outcomes. To examine adverse fetal/neonatal outcomes associated with SMM to determine if these outcomes were potentially preventable. A New Zealand national retrospective cohort study examining cases of SMM with an